← Browse by Condition
Medical Condition

thrombocytopenia neonatal alloimmune

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06449651 Phase 3
Recruiting

A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Enrollment
39 pts
Location
Belgium, Brazil, Fra...
Sponsor
Janssen Research & Development...
View Trial →